TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00193856 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01491243 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01032941 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00022516 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04220268 — Predictive Biomarker (PRD): GGN mRNA
Genes: GGN
Study NCT02719041 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study NCT03421405 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT03603847 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03225833 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02333344 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01484522 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03562429 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT03562429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03562429 — Safety Biomarker (SAF): Interleukin 1
Study NCT03562429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03562429 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study NCT03562429 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT02400814 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02041429 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02139852 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02139852 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02405546 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT02496468 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04300036 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT04300036 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03762226 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04198610 — Predictive Biomarker (PRD): MMP7 mRNA
Genes: MMP7; MPSL1; PUMP1
Study NCT02137902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02591862 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04141293 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04141293 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03890302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02465957 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00000515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05823389 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT04250324 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01521260 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03336099 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03691051 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01086267 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT04450862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00260923 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03855215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01210378 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03258671 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02121327 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01265953 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT01825551 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT00527982 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT01359189 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02965560 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02965560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02965560 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02965560 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT02965560 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT01192412 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03791151 — Predictive Biomarker (PRD): SLC31A1 mRNA
Genes: SLC31A1; COPT1; CTR1
Study NCT03791151 — Safety Biomarker (SAF): CTR1
Genes: SLC31A1; Hctr1
Study NCT00409149 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04045847 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT02092948 — Predictive Biomarker (PRD): PSCA mRNA
Genes: PSCA; UNQ206/PRO232
Study NCT00298675 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT01834365 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02779179 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02779179 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT02021903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01077310 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04361357 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04566432 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04566432 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04566432 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03993522 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00094380 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02972580 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02972580 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT03561779 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02868788 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03176004 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study NCT04830683 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT04830683 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04704245 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03089489 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT03318653 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02399397 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study NCT00221533 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01033747 — Predictive Biomarker (PRD): Liver iron
Study NCT02516592 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00701389 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01993719 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04077008 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02010385 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT04397757 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00652509 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01687946 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT00006406 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03614689 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03512197 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04091399 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01151423 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02678169 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02929810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00129142 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01200121 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04565535 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT02599727 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02138552 — Surrogate Endpoint (SUR): Bacterial count
Study NCT03907943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03006952 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02340039 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02270307 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04210063 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02175914 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT02424682 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00215852 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00554515 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02491840 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT02491840 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02491840 — Predictive Biomarker (PRD): HDAC4 mRNA
Genes: HDAC4; KIAA0288
Study NCT02491840 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT02491840 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT02491840 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT02491840 — Predictive Biomarker (PRD): ACKR3 mRNA
Genes: ACKR3; CMKOR1; CXCR7; GPR159; RDC1
Study NCT05179564 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02331927 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01673373 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01805037 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00288327 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01351805 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01351805 — Predictive Biomarker (PRD): TNFRSF1B mRNA
Genes: TNFRSF1B; TNFBR; TNFR2
Study NCT01351805 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01351805 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00715039 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01569971 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06159816 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06159816 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT06159816 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study NCT03450031 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03450031 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT03450031 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT03450031 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03450031 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT03450031 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT02660073 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03777319 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01871129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04715698 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01622777 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00180804 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study NCT03819972 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00328861 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02498808 — Predictive Biomarker (PRD): IFNL1 mRNA
Genes: IFNL1; IL29; ZCYTO21
Study NCT02498808 — Predictive Biomarker (PRD): IFNLR1 mRNA
Genes: IFNLR1; IL28RA; LICR2
Study NCT02498808 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01508637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03549689 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03197051 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT03008109 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02432963 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03855605 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04742062 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03378037 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03378037 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02051998 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03262441 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01334008 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03290716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03290716 — Safety Biomarker (SAF): Urinary microalbumin
Study NCT03135106 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00781937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00781937 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00216047 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00216047 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00013611 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00013611 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00650689 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01525082 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT01618149 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03954119 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00019929 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05836428 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01066559 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00059475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00059475 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02670967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03330834 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT03330834 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00003058 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT03622060 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00620269 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01590810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01793636 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03559790 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01472029 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04658563 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01808599 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03502577 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT02800083 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02325362 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00886353 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00622388 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01681693 — Predictive Biomarker (PRD): SLC47A1 mRNA
Genes: SLC47A1; MATE1
Study NCT01681693 — Predictive Biomarker (PRD): SLC22A3 mRNA
Genes: SLC22A3; EMTH; OCT3
Study NCT04521179 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04358185 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT01114776 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01114776 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00803634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02488070 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00302159 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04477993 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04057495 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02899026 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT03002714 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01336205 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT00423332 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02508077 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02508077 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03533205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03707847 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01130376 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03612908 — Predictive Biomarker (PRD): DIO2 mRNA
Genes: DIO2; ITDI2; TXDI2
Study NCT04563299 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04563299 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04457817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06531447 — Predictive Biomarker (PRD): Tubulin beta-3 chain
Genes: TUBB3; TUBB4
Study NCT02413047 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00416052 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02685904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00845299 — Predictive Biomarker (PRD): BAK1 mRNA
Genes: BAK1; BAK; BCL2L7; CDN1
Study NCT02920008 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04011293 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03668119 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT01898195 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01003249 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02485899 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT00338338 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00134771 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03713320 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT00932893 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01866839 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04064281 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01668576 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02458248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01699451 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00162110 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05822323 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05822323 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06152367 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00588562 — Predictive Biomarker (PRD): APRT mRNA
Genes: APRT
Study NCT03934268 — Predictive Biomarker (PRD): KCNQ2 mRNA
Genes: KCNQ2
Study NCT00820417 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00820417 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02381340 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02990468 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT00085566 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT01835236 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00003556 — Safety Biomarker (SAF): Interleukin 12
Study NCT00123240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02349711 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00057915 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT00057915 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03653247 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03653247 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01295827 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01295827 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03763149 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT03893747 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00645580 — Predictive Biomarker (PRD): SKAP2 mRNA
Genes: SKAP2; PRAP; RA70; SAPS; SCAP2; SKAP55R
Study NCT00436085 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4